Strategic transitions, such as Rx-to-OTC and CPG-to-CE switches, are powerful tools within the Life Cycle Management (LCM) process. These approaches not only extend the commercial lifespan of products but also unlock new revenue opportunities, expand market access, and position brands to meet evolving consumer and regulatory demands. Whether transitioning prescription drugs to over-the-counter status or repositioning consumer-packaged goods (CPG) as certified medical devices (CE), these strategies can significantly enhance a brand’s market presence and long-term value.
Our team specializes in managing both Rx-to-OTC and CPG-to-CE switches. We provide end-to-end guidance, from regulatory strategy development to consumer-focused marketing execution, ensuring every step of the process is smooth, compliant, and impactful.
For Rx-to-OTC switches, we focus on building consumer trust and navigating complex regulatory landscapes to enable seamless transitions. For CPG-to-CE transitions, we work to ensure compliance with medical device regulations while emphasizing product differentiation and market positioning.
With a data-driven approach and deep industry expertise, we help your brand unlock its full market potential, empowering you to reach broader audiences, maintain competitive advantage, and create lasting value in highly dynamic markets.
Our team worked on several switches (Rx to OTC or CPG to CE) such as; Lamisil®, Benzac®, Frontpro®, Viagra®, Actinica®, Sanature®, Etc..
Transitioning (/redesigning) prescription-only (Rx) products to Over the Counter (OTC) status is a transformative strategy that expands market access and enhances consumer convenience. Rx to OTC switches not only unlock significant growth opportunities but also empower consumers to take greater control of their health and wellness.
Our expertise in Rx to OTC switches includes:
- Market Assessment: Supporting comprehensive market analyses to identify suitable candidates for OTC conversion based on consumer demand, market trends, and competitive landscapes.
- Regulatory Assessment and Navigation: We support clients through the intricate regulatory pathways required for Rx to OTC transitions, ensuring compliance with local and international standards.
- Labelling and Consumer Communication: Support the development of clear, user-friendly labelling and educational materials to support safe and effective use by consumers.
- Clinical and Safety Evaluations: Support robust clinical data supports the safety and efficacy of the product in an OTC setting, meeting regulatory and consumer expectations.
- Launch and Commercial Strategy: Crafting tailored launch plans to maximize impact, including pricing strategies, distribution channels, and promotional activities.
By leveraging our deep industry knowledge, we help clients capitalize on Rx to OTC switches, driving growth while enhancing accessibility and consumer trust.